ABCDEFGHIJKLMNOPQRSTUVWXYZAAABAC
1
SchemaMoHCCN Clinical Field
(Fields in italics are identifier fields.
Fields in bold are required for data integrity purposes.)
Data TierRequirementsField DescriptionTypePermissible ValuesSourcemCODE Profile Name(s)mCODE FHIR Element / ARGO Data Element NameNotes
2
Sample Registrationprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
3
Sample Registrationsubmitter_donor_idIDRequiredUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}
Examples:
90234, BLD_donor_89, AML-90
mCODEmCODE STU1: Cancer Patient
mCODE STU2: Cancer Patient
mCODE STU1: Patient: Identifier
mCODE STU2: Patient: Identifier
4
Sample Registrationsubmitter_specimen_idIDRequiredUnique identifier of the specimen, assigned by the data provider.TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}
Examples:
LAML_PO, 00445, THY_099-tumour
mCODEmCODE STU1: Genetic Specimen
mCODE STU2: Genomic Specimen
mCODE STU1: Specimen.Identifier
mCODE STU2:
Specimen.identifier
5
Sample Registrationspecimen_tissue_sourceCoreRequiredTissue source of the biospecimen.TextAbdominal fluid (NCIt: C77611)
Amniotic fluid (NCIt: C13188)
Arterial blood (NCIt: C78729)
Bile (NCIt: C13192)
Blood derived - bone marrow
Blood derived - peripheral blood
Bone marrow fluid (SNOMED: 413679007)
Bone marrow derived mononuclear cells
Buccal cell (NCIt: C172264)
Buffy coat (NCIt: C84507)
Cerebrospinal fluid (NCIt: C12692)
Cervical mucus (SNOMED: 26859008)
Convalescent plasma (NCIt: C173750)
Cord blood (NCIt: C13300)
Duodenal fluid (SNOMED: 122574004)
Female genital fluid (SNOMED: 50473004)
Fetal blood (SNOMED: 737357006)
Hydrocele fluid (SNOMED: 725093005)
Male genital fluid (SNOMED: 23378005)
Pancreatic fluid (SNOMED: 17387004)
Pericardial effusion (NCIt: C3319)
Pleural fluid (NCIt: C77613)
Renal cyst fluid (SNOMED: 734111007)
Saliva (NCIt: C13275)
Seminal fluid (NCIt: C33529)
Serum (NCIt: C13325)
Solid tissue (NCIt: C164014)
Sputum (NCIt: C13278)
Synovial fluid (NCIt: C33718)
Urine (NCIt: C13283)
Venous blood (NCIt: C78730)
Vitreous fluid (NCIt: C13323)
Whole blood (Reference: NCIt: C41067)
Wound (Reference: SNOMED: 122566000)
mCODEmCODE STU1: Genetic Specimen
mCODE STU2: Genomic Specimen
mCODE STU1: Specimen.type
mCODE Value Set:Genetic Specimen Type Value Set

mCODE STU2:
Genomic Specimen Specimen Type Value Set
6
Sample Registrationtumour_normal_designationCoreRequiredDescription of specimen's tumour/normal status for data processing.TextNormal
Tumour
ICGC ARGOtumour_normal_designation
7
Sample Registrationspecimen_typeCoreRequiredDescription of the kind of specimen that was collected with respect to tumour/normal tissue origin.TextCell line - derived from normal
Cell line - derived from primary tumour
Cell line - derived from metastatic tumour
Cell line - derived from xenograft tumour
Metastatic tumour - additional metastatic
Metastatic tumour - metastasis local to lymph node
Metastatic tumour - metastasis to distant location
Metastatic tumour
Normal - tissue adjacent to primary tumour
Normal
Primary tumour - additional new primary
Primary tumour - adjacent to normal
Primary tumour
Recurrent tumour
Tumour - unknown if derived from primary or metastatic tumour
Xenograft - derived from primary tumour
Xenograft - derived from metastatic tumour
Xenograft - derived from tumour cell line
ICGC ARGOspecimen_type
8
Sample Registrationsubmitter_sample_idIDRequiredUnique identifier of the sample, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
hnc_12, CCG_34_94583, BRCA47832-3239
ICGC ARGOsubmitter_sample_id
9
Sample Registrationsample_typeCoreRequiredDescription of the type of molecular sample used for testing.
TextAmplified DNA
ctDNA
Other DNA enrichments
Other RNA fractions
polyA+ RNA
Protein
rRNA-depleted RNA
Total DNA
Total RNA
ICGC ARGOsample_type
10
Donorprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
11
Donorsubmitter_donor_idIDRequiredUnique identifier of the donor, assigned by the data provider.TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}}

Examples:
90234, BLD_donor_89, AML-90
mCODEmCODE STU1: Cancer Patient
mCODE STU2: Cancer Patient
mCODE STU1: Patient: Identifier
mCODE STU2: Patient: Identifier
12
DonorgenderCoreRequiredDescription of the donor self-reported gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.TextMan
Woman
Non-binary
Statistics Canada
13
Donorsex_at_birthCoreRequiredIndicate donor's sex assigned at birth.TextMale
Female
Other
14
Donoris_deceasedCoreRequiredIndicate if donor's last known status is deceased.BooleanYes
No
mCODEmCODE STU1: Cancer Patient
mCODE STU2: Cancer Patient
mCODE STU1: Patient.deceased.boolean
mCODE STU2: Patient.deceased.boolean
15
Donorlost_to_followup_after_clinical_event_identifierExtendedOptional/Conditional
This field can only be submitted if "is_deceased" = "No"
If the donor became lost to follow up, indicate the identifier of the clinical event (eg. submitter_primary_diagnosis_id, submitter_treatment_id or submitter_follow_up_id) after which the donor became lost to follow up.TextICGC ARGO
16
Donorlost_to_followup_reasonExtendedOptional/Conditional
This field should only be submitted if "lost_to_followup_after_clinical_event" was submitted.
Indicate reason the donor was lost to follow up.TextCompleted study
Discharged to palliative care
Lost contact
Not applicable
Unknown
Withdrew from study
17
Donordate_alive_after_lost_to_followupExtendedOptional/Conditional
If this field is submitted, then "lost_to_followup_after_clinical_event_identifier" must be submitted to indicate when the donor was lost to follow up.
Indicate the date when donor was discovered to be alive with unknown disease status after they had been lost to follow up.IntegerFormat YYYY-MMThis field should only be submitted if the donor was lost to follow up but discovered to be alive later on without knowing any cancer status information. The "lost_to_followup_after_clinical_event_identifier" field must be submitted if this field is submitted.
18
Donorcause_of_deathExtendedConditional
Only required if "is_deceased" is "Yes"
Indicate the cause of a donor's death.TextDied of cancer
Died of other reasons
Unknown
ICGC ARGOcause_of_death
19
Donordate_of_birthCoreRequiredIndicate donor's date of birth.IntegerFormat YYYY-MMmCODE mCODE STU1: Cancer Patient
mCODE STU2: Cancer.Patient
mCODE STU1: Patient.birthDate
mCODE STU2: Patient.birthDate
This field is required in order to calculate ARGO's required "age_at_diagnosis" field, which is recorded in years.
20
Donordate_of_deathCoreConditional
Only required if "is_deceased" is "Yes"
Indicate donor's date of death.IntegerFormat YYYY-MMmCODE mCODE STU1: Cancer Patient
mCODE STU2: Cancer.Patient
mCODE STU1: Patient.deceased.dateTime
mCODE STU2: Patient.deceased.dateTime
This field is required in order to calculate ARGO's required "survival_time" field which is recorded in days.
21
Donorprimary_siteCoreRequiredThe text term used to describe the primary site of disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O). This categorization groups cases into general categories.TextBreast (Reference: ICD-O C50)ICGC ARGOprimary_siteTo include multiple values, separate values with a pipe delimiter '|' within your file.
22
Specimenprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
23
Specimensubmitter_donor_idIDRequiredUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODEmCODE STU1: Cancer Patient
mCODE STU2: Cancer Patient
mCODE STU1: Patient: Identifier
mCODE STU2: Patient: Identifier
24
Specimensubmitter_specimen_idIDRequiredUnique identifier of the specimen, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}}

Examples:
LAML_PO, 00445, THY_099-tumour
mCODEmCODE STU1: Genetic Specimen
mCODE STU2: Genomic Specimen
mCODE STU1: Specimen.Identifier
mCODE STU2:
Specimen.identifier
25
Specimensubmitter_primary_diagnosis_idIDRequiredIndicate the primary diagnosis event in the clinical timeline that this specimen acquisition was related to.TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
LAML_PO, 00445, THY_099-tumour
mCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition
mCODE STU1: Condition.identifier
mCODE STU2: Condition.identifier
26
Specimenpathological_tumour_staging_systemCoreRequired/Conditional
This field is only required if the specimen is a tumour, and if clinical staging was not submitted.
Specify the tumour staging system used to assess the cancer at the time the tumour specimen was resected. Pathological classification is based on the clinical stage information (acquired before treatment) and supplemented/modified by operative findings and pathological evaluation of the resected specimen.TextAJCC 8th edition
AJCC 7th edition
AJCC 6th edition
Ann Arbor staging system
Binet staging system
Durie-Salmon staging system
FIGO staging system
International Neuroblastoma Risk Group Staging System
International Neuroblastoma Staging System

Lugano staging system
Rai staging system
Revised International staging system (R-ISS)
SEER staging system
St Jude staging system
ICGC ARGOpathological_tumour_staging_systemEither the clinical or pathological staging must be submitted.
27
Specimenpathological_t_categoryCoreRequired/Conditional
This field is required only if the selected pathological_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the stage of cancer defined by the size or contiguous extension of the primary tumour (T), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.TextClick for drop-down list of AJCC T category valuesmCODE
STU 1
mCODE STU1: TNM Pathological Primary Tumor Category
mCODE STU2: Staging Type for Primary Tumor Category Value Set: LOINC 21899-0
T category: TNM Primary Tumor Category Profile
mCODE STU1: Observation.value[x]:valueCodeableConcept
AJCC values from TNM Primary Tumor Category Value Set

mCODE STU2: Observation.value[x]
TNM Primary Tumor Category Value Se
t
28
Specimenpathological_n_categoryCoreRequired/Conditional
This field is required only if the selected pathological_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the stage of cancer defined by whether or not the cancer has reached nearby lymph nodes (N), according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.TextClick for drop-down list of AJCC N category valuesmCODE
STU 1
TNM Pathological Regional Nodes CategoryObservation.value[x]:valueCodeableConcept
AJCC values from TNM Regional Nodes Category Value Set
29
Specimenpathological_m_categoryCoreRequired/Conditional
This field is required only if the selected pathological_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the stage of cancer defined by whether there are distant metastases (M), meaning spread of cancer to other parts of the body, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.TextClick for drop-down list of AJCC M category valuesmCODE
STU 1
TNM Pathological Distant Metastases CategoryObservation.value[x]:valueCodeableConcept
AJCC values from TNM Distant Metastases Category Value Set
30
Specimenpathological_stage_groupCoreRequired/Conditional

This field is only required if the specimen is a tumour, and if clinical staging was not submitted.
Specify the tumour stage, based on pathological_tumour_staging_system, used to assess the cancer at the time the tumour specimen was resected.TextClick for drop-down list of pathological stage groupsICGC ARGOpathological_stage_groupThis field is dependent on the selected pathological_tumour_staging_system. Please refer to the documentation for Tumour Staging Classifications
31
Specimenspecimen_collection_dateCoreRequiredIndicate the date when the specimen was collected from donor.
TextFormat YYYY-MMmCODE
STU 1
mCODE STU1: Genetic Specimen
mCODE STU2: Genomic Specimen
Specimen.collection.collected.dateTime
Specimen.collection.collected[x].dateTime
This field is required in order to calculate the required ARGO "specimen_acquisition_interval" field which is recorded in days.
([specimen_collection_date] - [primary_diagnosis_date])
32
Specimenspecimen_storageExtendedRequiredIndicate the method of long term storage for specimen that were not extracted freshly or immediately cultured.TextCut slide
Frozen in -70 freezer
Frozen in liquid nitrogen
Frozen in vapour phase
Not Applicable
Other
Paraffin block
RNA later frozen
Unknown
ICGC ARGOspecimen_storage
33
Specimenspecimen_processingExtendedOptionalIndicate the technique used to process specimen.
TextCryopreservation in liquid nitrogen (dead tissue)
Cryopreservation in dry ice (dead tissue)
Cryopreservation of live cells in liquid nitrogen
Cryopreservation - other
Formalin fixed & paraffin embedded
Formalin fixed - buffered
Formalin fixed - unbuffered
Fresh
Other
Unknown
ICGC ARGOspecimen_processing
34
Specimentumour_histological_typeCoreRequired/Conditional
This field is only required if the specimen is a tumour.
The code to represent the histology (morphology) of neoplasms that is usually obtained from a pathology report, according to the International Classification of Diseases for Oncology, 3rd Edition (WHO ICD-O-3). Refer to the ICD-O-3 manual for guidelines at https://apps.who.int/iris/handle/10665/42344.TextICD-O-3 morphology codes

Values must meet the regular expression
^[8,9]{1}[0-9]{3}/[0,1,2,3,6,9]{1}[1-9]{0,1}$

Examples:
8260/3, 9691/36
mCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition

mCODE STU1: Condition.extension:histologyMorphologyBehavior
ICD-O-3 codes from Histology Morphology Behavior Value Set

mCODE STU2: Condition.extension:histologyMorphologyBehavior
ICD-O-3 codes from https://terminology.hl7.org/3.0.0/CodeSystem-icd-o-3.html
35
Specimenspecimen_anatomic_locationCoreRequiredIndicate the ICD-O-3 topography code for the anatomic location of a specimen when it was collected. Refer to the guidelines provided in the ICD-O-3 manual at https://apps.who.int/iris/handle/10665/42344TextICD-O-3 topography codes

Values must meet the regular expression
^[C][0-9]{2}(.[0-9]{1})?$

Examples:
C50.1, C18
mCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition
mCODE STU1: Condition.bodySite
ICD-O-3 topography codes from CancerBodyLocationVS ValueSet

mCODE STU2: ICD-O-3 topography codes from Condition.bodySite
36
Specimenspecimen_lateralityExtendedOptionalFor cancer in a paired organ, indicate the side on which the specimen was obtained. (Reference caDSR CDE ID 2007875)TextLeft
Not applicable
Right
Unknown
ICGC ARGOspecimen_laterality
37
Specimenreference_pathology_confirmed_diagnosisCoreRequired/Conditional
This field is only required if the specimen is a tumour.
Indicate whether the pathological diagnosis was confirmed by a (central) reference pathologist.TextYes
No
Not done
ICGC ARGOreference_pathology_confirmed
38
Specimenreference_pathology_confirmed_tumour_presenceCoreRequired/Conditional
This field is only required if the specimen is a tumour.
Indicate whether the (central) reference pathologist confirmed the presence of tumour in the specimen.TextYes
No
Not done
39
Specimentumour_grading_systemCoreRequired/Conditional
This field is only required if the specimen is a tumour.
Specify the tumour grading system used to assess the description of a tumour based on how abnormal the tumour cells and the tumour tissue look under a microscope. Tumour grade is an indicator of how quickly a tumour is likely to grow.TextFNCLCC grading system
Four-tier grading system
Gleason grade group system
Grading system for GISTs
Grading system for GNETs
IASLC grading system
ISUP grading system
Nottingham grading system
Nuclear grading system for DCIS
Scarff-Bloom-Richardson grading system
Three-tier grading system
Two-tier grading system
WHO grading system for CNS tumours
ICGC ARGOtumour_grading_system
40
Specimentumour_gradeCoreRequired/Conditional
This field depends on the selected tumour_grading_system, and is only required if the specimen is a tumour.
Grade of the tumour as assigned by the reporting tumour_grading_system.TextLow grade
High grade
GX
G1
G2
G3
G4
Low
High
Grade 1
Grade 2
Grade 3
Grade 4

Grade I
Grade II
Grade III
Grade IV
Grade Group 1
Grade Group 2
Grade Group 3
Grade Group 4
Grade Group 5
ICGC ARGOtumour_gradeRefer to the documentation for Tumour Grading Classifications
41
Specimenpercent_tumour_cells_rangeCoreRequired/Conditional
This field is only required if the specimen is a tumour.
Select the range representing the percent of tumour cells compared to the number of total cells in a specimen. (Reference: NCIt: C159484)Text0-19%
20-50%
51-100%
ICGC ARGOpercent_tumour_cells
42
Specimenpercent_tumour_cells_measurement_methodCoreRequired/Conditional
This field is only required if the specimen is a tumour.
Indicate method used to measure percent_tumour_cells.TextGenomics
Image analysis
Pathology estimate by percent nuclei
43
Primary Diagnosisprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
44
Primary Diagnosissubmitter_donor_idIDRequiredUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODEmCODE STU1: Cancer Patient
mCODE STU2: Cancer Patient
mCODE STU1: Patient: Identifier
mCODE STU2: Patient: Identifier
45
Primary Diagnosissubmitter_primary_diagnosis_idIDRequiredUnique identifier of the primary diagnosis event, assigned by the data provider.TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition
mCODE STU1: Condition.identifier
mCODE STU2: Condition.identifier
46
Primary Diagnosisdate_of_diagnosisCoreRequiredDate that the donor was first diagnosed with cancer. This date should be based on the earliest diagnosis.IntegerFormat YYYY-MMmCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition
Condition.extension:assertedDate (Primary Cancer Condition)
or
Condition.extension:assertedDate (Secondary Cancer Condition)
This field is required in order to calculate the required ARGO "age_at_diagnosis" field which is recorded in years (ie. [date_of_diagnosis]-[date_of_birth]).
47
Primary Diagnosiscancer_type_codeCoreRequiredThe code to represent the cancer type using the WHO ICD-10 code (https://icd.who.int/browse10/2019/en) classification.TextICD-10 codemCODEmCODE STU1: Primary Cancer Condition
mCODE STU2: Primary Cancer Condition
Condition.code (Primary Cancer Condition)
or
Condition.code (Secondary Cancer Condition)
ICD-10 codes from PrimaryOrUncertainBehaviorCancerDisorderVS
or
SecondaryCancerDisorderVS
48
Primary Diagnosisbasis_of_diagnosisCoreRequiredIndicate the most valid basis of how the primary diagnosis was identified. Terms are ordered in hierarchical order according to IACR guidelines, with the term at the top of the list ("Histology of primary tumour") being the more valid basis. If more than one diagnosis technique was used, select the most valid basis.TextHistology of a primary tumour
Histology of a metastasis
Cytology
Specific tumour markers
Clinical investigation
Clinical
Death certificate only
Unknown
IACR Standard for Basis of Diagnosis/ICGC ARGObasis_of_diagnosisIACR Definitions:
Death certificate only: Information provided is from a death certificate.
Clinical: Diagnosis made before death.
Clinical investigation: All diagnostic techniques, including X-ray, endoscopy, imaging, ultrasound, exploratory surgery (such as laparotomy), and autopsy, without a tissue diagnosis.
Specific tumour markers: Including biochemical and/or immunologic markers that are specific for a tumour site.
Cytology: Examination of cells from a primary or secondary site, including fluids aspirated by endoscopy or needle; also includes the microscopic examination of peripheral blood and bone marrow aspirates.
Histology of a metastasis: Histologic examination of tissue from a metastasis, including autopsy specimens.
Histology of a primary tumour: Histologic examination of tissue from primary tumour, however obtained, including all cutting techniques and bone marrow biopsies; also includes autopsy specimens of primary tumour.
Unknown: No information on how the diagnosis has been made.
49
Primary DiagnosislateralityExtendedOptionalFor cancer in a paired organ, indicate the side of the body on which the primary tumour or cancer first developed at the time of primary diagnosis. (Reference caDSR CDE ID 827)TextBilateral
Left
Midline
Not a paired site
Right
Unilateral, side not specified
Unknown
ICGC ARGOlaterality
50
Primary Diagnosislymph_nodes_examined_statusCoreRequiredIndicate if lymph nodes were examined for metastases.
TextCannot be determined
No
No lymph nodes found in resected specimen
Not applicable
Yes
ICGC ARGOlymph_nodes_examined_status
51
Primary Diagnosislymph_nodes_examined_methodCoreRequired/Conditional
This field is only required if "lymph_nodes_examined_status" is "Yes"
Indicate method used to examine lymph nodes.TextImaging
Lymph node dissection/pathological exam
Physical palpation of patient
ICGC ARGOlymph_nodes_examined_method
52
Primary Diagnosisnumber_lymph_nodes_positiveCoreRequired/Conditional
This field is only required if "lymph_nodes_examined_status" is "Yes"
The number of regional lymph nodes reported as being positive for tumour metastases (Reference: NCI CDE ID: 6113694)IntegerICGC ARGOnumber_lymph_nodes_positive
53
Primary Diagnosisclinical_tumour_staging_systemCoreRequired/Conditional
This field is only required if pathological staging is not submitted.
Indicate the tumour staging system used to stage the cancer at the time of primary diagnosis (prior to treatment).TextAJCC 8th edition
AJCC 7th edition
AJCC 6th edition
Ann Arbor staging system
Binet staging system
Durie-Salmon staging system
FIGO staging system
International Neuroblastoma Risk Group Staging System
International Neuroblastoma Staging System

Lugano staging system
Rai staging system
Revised International staging system (R-ISS)
SEER staging system
St Jude staging system
ICGC ARGOclinical_tumour_staging_systemEither the clinical or pathological staging must be submitted.
54
Primary Diagnosisclinical_t_categoryCoreRequired/Conditional
This field is required only if the selected clinical_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the extent of the primary tumour (T) based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.TextClick for drop-down list of AJCC T category valuesmCODE
STU 1
TNM Clinical Primary Tumor CategoryObservation.value[x]:valueCodeableConcept
AJCC values from TNM Primary Tumor Category Value Set
55
Primary Diagnosisclinical_n_categoryCoreRequired/Conditional
This field is required only if the selected clinical_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the stage of cancer defined by the extent of the regional lymph node (N) involvement for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.TextClick for drop-down list of AJCC N category valuesmCODE
STU 1
TNM Clinical Regional Nodes CategoryObservation.value[x]:valueCodeableConcept
AJCC values from TNM Regional Nodes Category Value Set
56
Primary Diagnosisclinical_m_categoryCoreRequired/Conditional
This field is required only if the selected clinical_tumour_staging_system is any edition of the AJCC cancer staging system
The code to represent the stage of cancer defined by the extent of the distant metastasis (M) for the cancer based on evidence obtained from clinical assessment parameters determined at time of primary diagnosis and prior to treatment, according to criteria based on multiple editions of the AJCC's Cancer Staging Manual. MX is NOT a valid category and cannot be assigned.TextClick for drop-down list of AJCC M category valuesmCODE
STU 1
TNM Clinical Distant Metastases CategoryObservation.value[x]:valueCodeableConcept
AJCC values from TNM Distant Metastases Category Value Set
57
Primary Diagnosisclinical_stage_groupCoreRequired/Conditional
This field is dependent on the selected clinical_tumour_staging_system. Refer to the documentation for Tumour Staging Classifications
Stage group of the tumour, as assigned by the reporting clinical_tumour_staging_system, that indicates the overall prognostic tumour stage (ie. Stage I, Stage II, Stage III etc.).TextClick for drop-down list of clinical stage groupsICGC ARGOclinical_stage_group

58
Treatmentprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
59
Treatmentsubmitter_donor_idIDRequiredUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer PatientPatient.Identifier
60
Treatmentsubmitter_treatment_idIDRequiredUnique identifier of the treatment, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
CancerRelatedRadiationProcedure
or
CancerRelatedMedicationStatement
or
CancerRelatedSurgicalStatement
Procedure.identifier
61
Treatmentsubmitter_primary_diagnosis_idIDRequiredIndicate the primary diagnosis event in the clinical timeline that this treatment was related toTextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Primary Cancer Condition
or
Secondary Cancer Condition
Condition.identifier
62
Treatmenttreatment_typeCoreRequiredIndicate the type of treatment regimen that the donor completed.
TextBone marrow transplant
Chemotherapy
Hormonal therapy
Immunotherapy
No treatment
Other targeting molecular therapy
Photodynamic therapy
Radiation therapy
Stem cell transplant
Surgery
ICGC ARGOtreatment_typeDepending on the treatment_type(s) selected, additional treatment details may be required to be submitted. For example, if treatment_type includes 'Chemotherapy', the supplemental Chemotherapy treatment type file is required. To include multiple values, separate values with a pipe delimiter '|' within your file.
63
Treatmentis_primary_treatmentCoreRequiredIndicate if the treatment was the primary treatment following the initial diagnosis (Reference: NCI)TextYes
No
ICGC ARGOis_primary_treatment
64
Treatmentline_of_treatmentExtendedOptionalIndicate the line of treatment.
IntegerICGC ARGOline_of_treatment
65
Treatmenttreatment_start_dateCoreRequiredIndicate the date treatment was initiated.IntegerFormat YYYY-MMmCODE
STU 1
If treatment_type = 'Radiation therapy' or 'Surgery':
CancerRelatedRadiationProcedure
or
CancerRelatedSurgicalStatement
Otherwise extend mCODE to use Procedure Profile



Procedure.performed.Period.start.dateTime (Radiation)
or
Procedure.performed.Period.start.dateTime (Surgery)
or
Procedure.performed.Period.start.dateTime (for all other treatment_types)
This field is required in order to calculate the ARGO required "treatment_start_interval" field which is recorded in days (ie. [treatment_start_date] - [date_of_diagnosis])
66
Treatmenttreatment_end_dateCoreRequiredIndicate the date treatment ended.IntegerFormat YYYY-MMmCODE
STU 1
If treatment_type = 'Radiation therapy' or 'Surgery':
CancerRelatedRadiationProcedure
or
CancerRelatedSurgicalStatement
Otherwise extend mCODE to use Procedure Profile



Procedure.performed.Period.end.dateTime (Radiation)
or
Procedure.performed.Period.end.dateTime (Surgery)
or
Procedure.performed.Period.end.dateTime (for all other treatment_types)
This field is required in order to calculate the ARGO required "treatment_duration" field which is recorded in days (ie. [treatment_end_date] - [treatment_start_date])
67
Treatmenttreatment_settingCoreRequiredIndicate the treatment setting, which describes the treatment's purpose in relation to the primary treatment. (Reference: CDISC [NCIt code: C124308])TextAdjuvant (Reference: NCIt C15675)
Advanced/Metastatic (Reference: NCIt: C14174)
Neoadjuvant (Reference: NCIt: C15665)
Conditioning (Reference: NCIt C188745)
Induction (Reference: NCIt C158876)
Locally advanced (Reference: NCIt C124451)
Maintenance (Reference NCIt C15688)
Mobilization (Reference: NCIt C62604)
Preventative (Reference: NCIt C124454)
Radiosensitization (Reference: NCIt C156596 and C15464)
Salvage (Reference: NCIt C15359)
ICGC ARGOtreatment_setting
68
Treatmenttreatment_intentCoreRequiredIndicate the intended disease outcome for which the treatment is given. (Reference: CDISC [NCIt code: C124307])TextCurative (Reference: SNOMED: 373808002)
Palliative (Reference: SNOMED: 363676003)
Supportive (Reference: SNOMED: 399707004)
Diagnostic (Reference: SNOMED:
261004008)
Preventive (Reference: SNOMED:
129428001)
Guidance (Reference: SNOMED:
429892002)
Screening (Reference: SNOMED:
360156006)
Forensic (Reference: SNOMED:
447295008)
mCODE
STU
CancerRelatedRadiationProcedure
or
CancerRelatedMedicationStatement
or
CancerRelatedSurgicalStatement

mCODE Value Set: Procedure Intent
69
Treatmentdays_per_cycleExtendedOptionalIndicate the number of days in a treatment cycle.IntegerICGC ARGOdays_per_cycle
70
Treatmentnumber_of_cyclesExtendedOptionalIndicate the number of treatment cycles.IntegerICGC ARGOnumber_of_cycles
71
Treatmentresponse_to_treatment_criteria_methodCoreRequiredIndicate the criteria used to assess the donor's overall response to the applied treatment regimen. TextClick for drop-down list of response criteria methodsICGC ARGOresponse_to_treatment_criteria_method
72
Treatment response_to_treatmentCoreRequiredIndicate the donor's response to the applied treatment regimen as assigned by the reporting response_to_treatment_criteria_method.
TextPhysician assessed partial responseICGC ARGO response_to_treatment
73
Treatmentstatus_of_treatmentExtendedOptionalIndicate the donor's status of the prescribed treatment.TextTreatment completed as prescribed
Treatment incomplete due to technical or organizational problems
Treatment incomplete because patient died
Patient choice (stopped or interrupted treatment)
Physician decision (stopped or interrupted treatment)
Treatment stopped due to lack of efficacy (disease progression)
Treatment stopped due to acute toxicity
Other
Not applicable
Unknown
ICGC ARGOoutcome_of_treatment
74
Chemotherapyprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
75
Chemotherapysubmitter_donor_idIDRequiredUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer PatientPatient.Identifier
76
Chemotherapysubmitter_treatment_idIDThe Chemotherapy file is only required if "Chemotherapy" is selected in "treatment_type" fieldUnique identifier of the treatment, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}
mCODE
STU 1
Cancer Related Medication StatementMedicationStatement.identifier
77
Chemotherapydrug_reference_databaseCoreRequiredIndicate the reference drug database where drug name is found.TextRxNorm
PubChem
NCI Thesaurus
78
Chemotherapydrug_nameCoreRequiredName of agent or drug administered to patient as part of the treatment regimen.
TextIndicate the drug name as it exists in the database specified in the drug_reference_database.ICGC ARGOdrug_nameRxNorm: You can search for RXNorm values through the web interface (https://mor.nlm.nih.gov/RxNav/) or API (https://lhncbc.nlm.nih.gov/RxNav/APIs/RxNormAPIs.html).

PubChem: https://pubchem.ncbi.nlm.nih.gov/
NCI Thesaurus: https://ncithesaurus.nci.nih.gov/ncitbrowser/
79
Chemotherapydrug_reference_identifierCoreRequiredIndicate the unique drug database identifier assigned to the treatment regimen drug.TextIndicate the identifier from the "drug_reference_database" for the drug.mCODE
STU 1
Cancer-Related Medication AdministrationMedicationAdministration.medication[x]This field is required in order to validate required ARGO 'drug_name' field

- RxNorm requires the RXCUI. For example, to find the rxnormcui based on drug name, you can use: https://rxnav.nlm.nih.gov/REST/rxcui.json?name=leucovorin or https://mor.nlm.nih.gov/RxNav/search?searchBy=String&searchTerm=leucovorin
- PubChem requires the PubChem Concept ID
- NCI Thesaurus requires the NCI Thesaurus code
80
Chemotherapychemotherapy_drug_dose_unitsCoreRequired if cumulative drug dose is submitted.Indicate units used to record chemotherapy drug dose.Textmg/m2
IU/m2
ug/m2
g/m2
mg/kg
IU/kg
ICGC ARGOchemotherapy_dosage_units
81
Chemotherapyprescribed_cumulative_drug_doseExtendedOptionalIndicate the total prescribed cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.NumberIndicate the total prescribed cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.ICGC ARGOcumulative_drug_dosage
82
Chemotherapyactual_cumulative_drug_doseExtendedOptionalIndicate the total actual cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.NumberIndicate the total actual cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.ICGC ARGOcumulative_drug_dosage
83
Hormone Therapyprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
84
Hormone Therapysubmitter_donor_idIDThe Hormone Therapy file is only required if "Hormonal Therapy" is selected in "treatment_type" fieldUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer PatientPatient.Identifier
85
Hormone Therapysubmitter_treatment_idIDRequiredUnique identifier of the treatment, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer Related Medication StatementMedicationStatement.identifier
86
Hormone Therapydrug_reference_databaseCoreRequiredIndicate the reference drug database where drug name is found.TextRxNorm
PubChem
NCI Thesaurus
87
Hormone Therapydrug_nameCoreRequiredName of agent or drug administered to patient as part of the treatment regimen.
TextIndicate the drug name as it exists in the database specified in the drug_reference_database.ICGC ARGOdrug_nameYou can search for RX Norm values through the web interface (https://mor.nlm.nih.gov/RxNav/) or API (https://lhncbc.nlm.nih.gov/RxNav/APIs/RxNormAPIs.html).
For example, to find the rxnormcui based on drug name, you can use: https://rxnav.nlm.nih.gov/REST/rxcui.json?name=leucovorin or https://mor.nlm.nih.gov/RxNav/search?searchBy=String&searchTerm=leucovorin
88
Hormone Therapydrug_reference_identifierCoreRequiredIndicate the unique drug database identifier assigned to the treatment regimen drug.Text
Indicate the identifier from the "drug_reference_database" for the drug.
mCODE
STU 1
Cancer-Related Medication AdministrationMedicationAdministration.medication[x]This field is required in order to validate required ARGO 'drug_name' field

- RxNorm requires the RXCUI. For example, to find the rxnormcui based on drug name, you can use: https://rxnav.nlm.nih.gov/REST/rxcui.json?name=leucovorin or https://mor.nlm.nih.gov/RxNav/search?searchBy=String&searchTerm=leucovorin
- PubChem requires the PubChem Concept ID
- NCI Thesaurus requires the NCI Thesaurus code
89
Hormone Therapyhormone_drug_dose_unitsCoreRequired if cumulative drug dose is submitted.Indicate the units used to record hormone drug dose.
Textmg/m2
IU/m2
ug/m2
g/m2
mg/kg
IU/kg
ICGC ARGOhormone_drug_dosage_units
90
Hormone Therapyprescribed_cumulative_drug_doseExtendedOptionalIndicate the total prescribed cumulative drug dose in the same units specified in hormone_drug_dose_units.NumberIndicate the total prescribed cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.ICGC ARGOcumulative_drug_dosage
91
Hormone Therapyactual_cumulative_drug_doseExtendedOptionalIndicate the total actual cumulative drug dose in the same units specified in hormone_drug_dose_units.NumberIndicate the total actual cumulative drug dose in the same units specified in chemotherapy_drug_dose_units.ICGC ARGOcumulative_drug_dosage
92
Radiationprogram_idIDRequiredUnique identifier of the program.TextUnique identifier of the MOH program.ICGC ARGOprogram_id
93
Radiationsubmitter_donor_idIDThe Radiation file is only required if "Radiation therapy" is selected in "treatment_type" fieldUnique identifier for the donor, assigned by the data provider. TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer PatientPatient.Identifier
94
Radiationsubmitter_treatment_idIDRequiredUnique identifier of the treatment, assigned by the data provider.
TextValues must meet the regular expression
^[A-Za-z0-9\-\._]{1,64}

Examples:
90234, BLD_donor_89, AML-90
mCODE
STU 1
Cancer Related Radiation ProcedureProcedure.identifier
95
Radiationradiation_therapy_modalityCoreRequiredIndicate the method of radiation treatment or modality.
TextMegavoltage radiation therapy using photons (procedure)
Teleradiotherapy using electrons (procedure)
Teleradiotherapy protons (procedure)
Teleradiotherapy neutrons (procedure)
Brachytherapy (procedure)
Radiopharmaceutical
Other
mCODE
STU 1
Cancer Related Radiation ProcedureProcedure.code
mCODE Value Set: Radiation Procedure Value Set
96
Radiationradiation_therapy_typeCoreRequiredIndicate type of radiation therapy administered.
TextExternal
Internal
ICGC ARGOradiation_therapy_type
97
Radiationradiation_therapy_fractionsCoreRequiredIndicate the total number of fractions delivered as part of treatment.
IntegermCODE
STU 1
Cancer Related Radiation ProcedureRadiationFractionsDelivered
98
Radiationradiation_therapy_dosageCoreRequiredIndicate the total dose given in units of Gray (Gy).IntegermCODE
STU 1
Cancer Related Radiation ProcedureTotalRadiationDoseDelivered
99
Radiationanatomical_site_irradiated CoreRequiredIndicate localization site where radiation therapy was administered.TextClick for drop-down list of sites.Cancer Care Ontario
100
Radiationradiation_boostExtendedOptionalA radiation boost is an extra radiation treatment targeted at the tumor bed, given after the regular sessions of radiation is complete (Reference NCIt: C137812). Indicate if this radiation treatment was a radiation boost.TextYes
No